These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16553537)

  • 41. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obsessive-compulsive disorder: diagnosis and treatment.
    Goodman WK
    J Clin Psychiatry; 1999; 60 Suppl 18():27-32. PubMed ID: 10487253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    Lydiard RB
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.
    Cheer SM; Figgitt DP
    Paediatr Drugs; 2001; 3(10):763-81. PubMed ID: 11706925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.
    Gorman JM; Kent JM
    J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obsessive-compulsive disorder-related disorders: the role of selective serotonergic reuptake inhibitors.
    Hollander E
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():75-87. PubMed ID: 9032004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy].
    Todorov C
    Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of obsessive-compulsive disorder in patients who have comorbid major depression.
    Abramowitz JS
    J Clin Psychol; 2004 Nov; 60(11):1133-41. PubMed ID: 15389622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review of Scientific Studies and Case Reports on Music and Obsessive-Compulsive Disorder.
    Truong TPA; Applewhite B; Heiderscheit A; Himmerich H
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SSRIs: Prozac and company - part I.
    Harv Ment Health Lett; 2000 Oct; 17(4):1-3. PubMed ID: 11015755
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacological guidelines for the treatment of refractory patients with obsessive-compulsive disorder].
    Toro-Martínez E
    Vertex; 2005; 16(64):442-5. PubMed ID: 16314898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders].
    Rosenberg R
    Ugeskr Laeger; 2001 Apr; 163(14):1985-91. PubMed ID: 11307357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impulse control disorders in patients with obsessive-compulsive disorder.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):30-7. PubMed ID: 15679537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beyond refractory obsessions and anxiety states: toward remission.
    Hollander E; Zohar J
    J Clin Psychiatry; 2004; 65 Suppl 14():3-5. PubMed ID: 15554781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
    Chouinard G
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():37-41. PubMed ID: 1484177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
    Van Ameringen M; Mancini C; Patterson B; Bennett M
    Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.